# Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

> **NCT00407056** · PHASE3 · COMPLETED · sponsor: **Sirion Therapeutics, Inc.** · enrollment: 20 (—)

## Conditions studied

- Uveitis
- Panuveitis

## Interventions

- **DRUG:** Difluprednate Ophthalmic Emulsion

## Key facts

- **NCT ID:** NCT00407056
- **Lead sponsor:** Sirion Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407056, "Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00407056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*